DOĞAN, S. Et Al. 2011. Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha myeloperoxidase and nitrotyrosine in primary Sjögren’s Syndrome. 36th FEBS Congress, Biochemistry for Tomorrow's Medicine , (TORİNO, Italy), 59.

DOĞAN, S., ÇAY, H. F., SEZER, İ., FELEK, R., & AYDIN ASLAN, M., (2011). Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha myeloperoxidase and nitrotyrosine in primary Sjögren’s Syndrome . 36th FEBS Congress, Biochemistry for Tomorrow's Medicine (pp.59). TORİNO, Italy

DOĞAN, SERDAR Et Al. "Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha myeloperoxidase and nitrotyrosine in primary Sjögren’s Syndrome," 36th FEBS Congress, Biochemistry for Tomorrow's Medicine, TORİNO, Italy, 2011

DOĞAN, SERDAR Et Al. "Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha myeloperoxidase and nitrotyrosine in primary Sjögren’s Syndrome." 36th FEBS Congress, Biochemistry for Tomorrow's Medicine , TORİNO, Italy, pp.59, 2011

DOĞAN, S. Et Al. (2011) . "Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha myeloperoxidase and nitrotyrosine in primary Sjögren’s Syndrome." 36th FEBS Congress, Biochemistry for Tomorrow's Medicine , TORİNO, Italy, p.59.

@conferencepaper{conferencepaper, author={SERDAR DOĞAN Et Al. }, title={Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha myeloperoxidase and nitrotyrosine in primary Sjögren’s Syndrome}, congress name={36th FEBS Congress, Biochemistry for Tomorrow's Medicine}, city={TORİNO}, country={Italy}, year={2011}, pages={59} }